Tempus AI (TEM) Stock Price, News & Analysis

Company Overview

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Key Stats

• Today's Range: $77.01 to $77.01
• 50-Day Range: $31.83 to $89.44
• 52-Week Range: $22.89 to $91.45
• Volume: 417,156 shs
• Average Volume: 13.98 million shs
• Market Capitalization: $11.92 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $58.55
• Consensus Rating: Moderate Buy

Tempus AI Stock Analysis - MarketRank™

Tempus AI scored higher than 29% of companies evaluated by MarketBeat, and ranked 817th out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Tempus AI has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 8 buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Tempus AI has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Tempus AI are expected to grow in the coming year, from ($6.15) to ($1.33) per share.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

24.39% of the float of Tempus AI has been sold short.

Short Interest Ratio / Days to Cover

Tempus AI has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tempus AI has recently increased by 9.86%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Tempus AI does not currently pay a dividend.

Dividend Growth

Tempus AI does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

24.39% of the float of Tempus AI has been sold short.

Short Interest Ratio / Days to Cover

Tempus AI has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Tempus AI has recently increased by 9.86%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.41

News Sentiment

Tempus AI has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 46 news articles for Tempus AI this week, compared to 12 articles on an average week.

Search Interest

209 people have searched for TEM on MarketBeat in the last 30 days. This is an increase of 386% compared to the previous 30 days.

MarketBeat Follows

221 people have added Tempus AI to their MarketBeat watchlist in the last 30 days. This is an increase of 295% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Tempus AI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $130,542,311.00 in company stock.

Percentage Held by Institutions

Only 24.22% of the stock of Tempus AI is held by institutions.

TEM Stock Analysis - Frequently Asked Questions

How have TEM shares performed this year?

Tempus AI's stock was trading at $33.76 on January 1st, 2025. Since then, TEM shares have increased by 127.3% and is now trading at $76.72.
View the best growth stocks for 2025 here.

When did Tempus AI IPO?

Tempus AI (TEM) raised $411 million in an initial public offering on Friday, June 14th 2024. The company issued 11,100,000 shares at $37.00 per share.

Who are Tempus AI's major shareholders?

Tempus AI's top institutional shareholders include ARK Investment Management LLC (3.51%), Revolution Growth Management Company Inc. (2.20%), Sumitomo Mitsui Trust Group Inc. (2.06%) and Nikko Asset Management Americas Inc. (2.06%). Insiders that own company stock include Bradley A Keywell, Eric P Lefkofsky, Ryan Fukushima, Andrew Polovin, James William Rogers, Erik Phelps, Ryan M Bartolucci, Jennifer A Doudna and David R Epstein.
View institutional ownership trends.

How do I buy shares of Tempus AI?

Shares of TEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Tempus AI own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Tempus AI investors own include AST SpaceMobile (ASTS), NVIDIA (NVDA), Broadcom (AVGO), Micron Technology (MU), Recursion Pharmaceuticals (RXRX), Genius Sports (GENI) and Super Micro Computer (SMCI).

Company Calendar

• Today: 2/20/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Computer programming, data processing, & other computer related
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:TEM
• Previous Symbol: NASDAQ:TEM
• CUSIP: N/A
• CIK: 1717115
• Web: www.tempus.com
• Phone: 800-976-5448
• Fax: N/A
• Employees: 2,300
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $58.55
• High Stock Price Target: $74.00
• Low Stock Price Target: $44.00
• Potential Upside/Downside: -23.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 12 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-289,810,000.00
• Net Margins: N/A
• Pretax Margin: -190.28%
• Return on Equity: N/A
• Return on Assets: -111.38%

Debt

• Debt-to-Equity Ratio: 8.17
• Current Ratio: 2.69
• Quick Ratio: 2.55

Sales & Book Value

• Annual Sales: $320.67 million
• Price / Sales: 37.67
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 157,450,000
• Free Float: N/A
• Market Cap: $12.08 billion
• Optionable: N/A
• Beta: N/A